News | Cardiac Imaging | September 01, 2015

Pie Medical Imaging Recognized for Innovation in Quantitative Cardiovascular Software

Company receives European award for technology leadership from Frost & Sullivan

Pie Medical Imaging, Frost & Sullivan, technology leadership, CAAS, cardiovascular diagnostics

CAAS MRV is part of Pie Medical Imaging's suite of imaging solutions for quantitative cardiovascular diagnosis and treatment planning.

September 1, 2015 — Based on its recent analysis of the cardiovascular image management market, Frost & Sullivan recognizes Pie Medical Imaging (PMI) with the 2015 European Frost & Sullivan Award for Technology Leadership. The Netherlands-based PMI has designed innovative and easy-to-use imaging solutions — its CAAS and 3mensio product lines — which deliver precise and reproducible quantitative results for cardiovascular diagnosis and treatment planning. By improving the quality of cardiovascular diagnostics and interventions, the software is effectually facilitating next-generation research on the efficacy of novel intervention methods.

Among existing imaging modalities, cardiovascular magnetic resonance imaging (CMR) plays a role of growing importance in the assessment of patients with heart failure (HF). Currently, it is difficult to study the myocardial perfusion status in HF due to left ventricular (LV) remodeling and wall thinning, coexistent scars and respiratory artefacts. There is an urgent need for state-of-the-art imaging modalities with software algorithms to diagnose cardiovascular diseases accurately and at an early stage. In response to this need, PMI developed CAAS MRV, a sophisticated software that provides quantitative analyses of cardiovascular magnetic resonance images.

Left and right ventricular analysis from CMR datasets and blood flow measurements from velocity-encoded MR will assist the medical specialist in selecting the best treatment options. For flow analysis, PMI offers CAAS MR Flow and recently released its highly innovative CAAS MR 4D Flow to complete its CMR analysis portfolio.

During interventional procedures, as performed in the catheterization laboratory under X-ray guidance, other analysis tools are required. "Unlike visual estimations of coronary artery dimensions, CAAS QCA automatically determines stenosis severity, which refines the visual estimate and provides objective and reproducible measurements of several important features of the coronary anatomy," said Frost & Sullivan Industry Analyst Darshana De. "To develop the CAAS platform further, PMI has more than 60 full-time R&D resources dedicated to developing and optimizing the advanced visualization and analysis software."

PMI is the market leader in cardiovascular analysis software for cardiology and radiology. Its CAAS and 3mensio brands offer a broad range of products for the analysis of X-ray, MRI, computed tomography (CT), optical coherence tomography (OCT) and intravascular ultrasound (IVUS) images. Its unique products provide:

  • Aortic regurgitation analysis based on X-ray angiography for use in aortic valve replacement procedures (CAAS A-valve);
  • Vessel analysis from MR datasets for research, including bifurcation analysis, vessel wall determination and plaque composition analysis (CAAS MRA);
  • Pre-op planning software for aortic valve, mitral valve and left atrial appendage interventions based on CT imaging (3mensio Structural Heart);
  • Abdominal aneurysm repair (EVAR) analysis software based on CT imaging (3mensio Vascular); and
  • 3-D coronary reconstruction and analysis from two X-ray projections (CAAS QCA3D).

PMI has close ties with research institutions in Europe, the United States, Japan and Australia. These partnerships include evaluation studies and co-development of products and solutions. It also works with core labs such as CRF, New York and Cardialysis in Rotterdam to study the efficacy of new treatment methods.

"PMI's CAAS Workstation is a stand-alone modular software product for the viewing and quantification of X-ray angiographic images and runs on a standard personal computer," noted De. "Its quantitative analyses results are based on semi-automatic contour detection forms and can be exported in various formats across different consoles, independent of the type of vendor acquisition equipment."

The CAAS Workstation offers segmentation of different cardiovascular structures, 3-D reconstruction of vessel segments based on two X-ray projections, as well as measurement and reporting tools. It aids in calculating the dimensions of cardiovascular structures, quantifying stenosis in coronary and peripheral vessels, the motion quantification of left and right ventricular walls, as well as stent visualization and dimension measurement.

For more information: www.piemedicalimaging.com

Related Content

Philips Launches Azurion With FlexArm
Technology | Angiography | January 17, 2019
Philips announced the launch of Azurion with FlexArm, designed to enhance positioning flexibility for image-guided...
NewYork-Presbyterian Hospital Partners With Philips for Health IT and Clinical Informatics
News | Enterprise Imaging | January 16, 2019
Philips announced that NewYork-Presbyterian Hospital has chosen to implement the company’s IntelliSpace Enterprise...
Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...
Videos | Advanced Visualization | January 09, 2019
Vinodh Kumar, M.D., and Komal Shah, M.D., associate professors of radiology at...
3-D Reconstruction of Ichthyosaurus Skull

A 3-D reconstruction of the ichthyosaurus skull from a computed tomography (CT) scan. Image courtesy of Nigel Larkin, taken at Royal Veterinary College, London.

News | Computed Tomography (CT) | January 09, 2019
A nearly meter-long skull of a giant fossil marine ichthyosaur found in a farmer's field more than 60 years ago has...
SCCT Releases New Guideline for CT Use During TAVR
News | Computed Tomography (CT) | January 08, 2019
The Society of Cardiovascular Computed Tomography (SCCT) has released a new expert consensus document for computed...
Shimadzu Medical Systems USA Acquires Core Medical Imaging
News | Digital Radiography (DR) | January 08, 2019
Shimadzu Medical Systems USA has acquired Core Medical Imaging Inc. (CMI) in order to further expand its healthcare...
Hypertension With Progressive Cerebral Small Vessel Disease Increases Cognitive Impairment Risk
News | Magnetic Resonance Imaging (MRI) | January 08, 2019
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...